Off the wire
Japan will not relocate embassy from Tel Aviv to Jerusalem: FM  • Russia's Lavrov tells Tillerson U.S. tension-raising on Korean Peninsula "inadmissible"  • Melbourne SUV attack suspect due in court for 18 counts of attempted murder  • China treasury bond futures open lower Wednesday  • China Hushen 300 index futures open mixed Wednesday  • Yearender: Middle East power struggle threatens shaky peace in post-IS phase  • Chinese shares open lower Wednesday  • China's industrial profits up 21.9 pct in first 11 months  • Market exchange rates in China -- Dec. 27  • Yearender: China, Sri Lanka's joint development in Hambantota rockets from vision to reality in 2017  
You are here:  

200,000 more children vaccinated against Japanese Encephalitis in Myanmar's Rakhine state

Xinhua,December 27, 2017 Adjust font size:

YANGON, Dec. 27 (Xinhua) -- A total of 200,000 more children under five years of age in Myanmar's western Rakhine state were vaccinated against Japanese Encephalitis, the official Global New Light of Myanmar reported Wednesday.

The inoculation campaign, launched by the Rakhine state Health Department, covered 14 townships including Sittway, Mrauk U, Maungtaw, Kyaukphyu and Thandwe.

Moreover, more than 40,000 children in far-flung border areas in the state were also immunized from the deliberating mosquito-borne disease during the period.

The first round of the campaign, which lasted from Nov. 15 to 23, had given vaccination to 470,580 children between the age of 5 years and 15 years under the Rakhine state program.

The vaccination targets a total of 14 million children in Rakhine.

Japanese Encephalitis virus is maintained in a cycle involving mosquitoes and vertebrate hosts, mainly pigs and wading birds. Humans can be infected when bitten by an infected mosquito.

Some infected patients will develop neurological symptoms including tremors, seizures (especially among children), as well as mental status changes and movement disorders.

Japanese Encephalitis can be fatal in 20 to 30 percent of cases and most of survivors continue to have neurologic, cognitive or psychiatric symptoms. Enditem